TSH biopharm Corporation LTD.

TSH's vision is committed to improving the quality of life of patients with chronic diseases.

Prescription Medicine
TSH focuses on the development of patentable & high barrier specialty drugs with Pharmaco-economic profile. Our culture is working with honesty, integrity, entrepreneurship. We commit and contribute to society by integrating professional methods in science, our innovative mindset, and the team work spirit. Meanwhile, we are going to be a best partner for global pharmaceutical companies in drug developing & Asia marketing expert.

Comprehensive liquid biopsy
TSH liquid biopsy combines the CTC “CMxTM” platform with the next generation sequencing (NGS) “SMSEQTM” platform to form a complete cancer monitoring system.
It can provide a comprehensive liquid biopsy for heredity cancer risk assessment, high risk cancer patients’ screening, druggable genes detection and treatment monitoring.

Tzu Chi University of Science and Technology/Hualien District Agricultural Research and Extension St

Our team has conducted an in-depth research on Nostoc commune. We are able to effectively culture a large number of individuals, especially ones spherical in shape (usually found flattened in nature). Its potential uses in health care and skin care products can create novel opportunities in the biomedical industry. Nostoc commune is rich in alginic acid and phycobiliprotein, which makes it a great antioxidant, stimulating cell repair and anti-aging. In addition, Nostoc commune is rich in polysaccharides and fluorescent proteins. The future application of Nostoc commune in solid state fluorescence can further increase its commercial value.

Utek International Corporation

Cell Immunotherapy System, Isolator, VHPS generator

VSense Medical Inc.

in-vitro diagnostic

VtR INCORPORATED

Genetic Testing

WELGENE BIOTECH CO., LTD.

暫不提供

WISH IN COMPANY LIMITED

COVID-19(SARS-CoV2) IgM/IgG Antibody Rapid Test

WishTech Co., Ltd

Our MCS®+ multicomponent collection system is dedicated to blood component collection including platelets, plasma, and red blood cells, and also performs therapeutic procedures. The system has single needle technology for a simple, more comfortable procedure and automated draw and return speeds that adjust to each donor’s unique flow capabilities. The MCS+ system comes with optional saline that replenishes fluids lost during donation, citrate control and monitoring to ensure the comfort of your donors, and quiet operation that is ideal for donor and patient environments. Additionally, the system incorporates protocol card technology for instant access to multiple procedures, flexibility to produce the right products from the right donors at the right time to meet patient needs, and a complete disposable set for all component combinations and patient treatments.

Yourgene Health Co., Ltd.

• Clinical oncology research: Breast Cancer cfDNA Assay, Colon Cancer cfDNA Assay, Lung Cancer cfDNA Assay, Pan-Cancer Cell-Free Assay, Oncomine Comprehensive Assay
• NGS research services: whole genome sequencing, whole exome sequencing, metagenomic sequencing and RNA sequencing
• Instrument for DNA fragment size selection：QS250 (Lightbench™)
• COVID-19 testing service
• Leading NIPT solutions for labs and clinicians: Sage™ prenatal screen and the IONA® test - The IONA® test is the first complete CE-IVD product for labs wishing to offer their own in-house (NIPT) service
• Contract development partnership
• Reproductive health: Pre-implantation Genetic Screening(PGS), Rapid aneuploidy analysis, Male factor infertility and pregnancy loss
• Pharmacogenetics
• Genetic disease diagnostics: Cancer panel, Cardiomyopathy disease panel, Sudden Cardiac Death panel, BRCA1/2 Genetic Testing

Yourgene Health, Inc

\\\\\\\\\\\\\\\"• Clinical oncology research
• NGS research services: whole genome sequencing, whole exome sequencing and metagenomic sequencing
• Leading NIPT solutions for labs and clinicians: Sage™ prenatal screen and the IONA® test - The IONA® test is the first complete CE-IVD product for labs wishing to offer their own in-house (NIPT) service
• Contract development partnership
• Reproductive health
• Pharmacogenetics
• Genetic disease diagnostics\\\\\\\\\\\\\\\"